SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" crypto is trending as its community rallies behind its multichain functionality and deflationary mechanics. Discussions highlight the token's potential to "mint millionaires" and its strong community bond, especially the collaboration with other meme coins. Some users are pointing to the upcoming Thanksgiving holiday as a chance to spread the word to family.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a surge in price and volume, fueled by a flurry of press releases about its technology's role in securing global trade, particularly in the precious metals sector. The stock's low float and potential short squeeze are key talking points among traders, with some drawing comparisons to other high-flying stocks. However, concerns about potential dilution and the company's financial history are also prevalent in community discussions.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network ($REACT) is trending as chatter increases around its potential to unify Ethereum Layer 2s, with the community actively discussing its first-mover advantage and potential integration with new Ethereum infrastructure. The recent Grok 4.1 on EIL announcement is also a key catalyst, alongside speculation around new exchange listings and a growing number of token holders. Community members are highlighting its potential as core infrastructure for a unified Ethereum.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

Bitwise's XRP ETF is a major catalyst driving interest in XRP, with the community actively discussing the potential impact of these ETFs absorbing a significant portion of the token's supply. Discussions include speculation on future price movements and comparisons to other cryptocurrencies and traditional financial systems. Investors are also weighing the potential for XRP to integrate with real-world assets and broader financial infrastructure.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending due to community excitement around its potential as foundational infrastructure for TradFi, emphasized by its high throughput and compliance-aware design. Investors are actively discussing the token's value proposition in comparison to major platforms like Amazon, Google, and Microsoft, viewing KTA as a targeted bet on the future of financial plumbing. The community also highlights potential partnerships, particularly with Stripe, as a key catalyst.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as investors discuss the company's potential turnaround, highlighted by strong Q3 earnings, a jump in gross margins, and a substantial pension reversion poised to significantly reduce debt. The community is focused on margin acceleration, expansion in AM&C, steady film demand, and the possibility of the company becoming net cash positive, leading to speculation about future pharma contracts and growth opportunities.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

OPGN is trending as community members discuss the company's potential relisting on the Nasdaq and the launch of its CapForce platform. The focus is on AEI Capital's involvement and possible impacts on the stock's valuation. Some investors express long-held frustrations alongside newfound optimism for the company's future as a fintech player.

Global X Funds - Global X Silver Miners ETF

SIL is trending due to recent strength in silver prices and speculation about a potential breakout, leading to increased trading volume. The community is discussing the possibility of SIL reaching new all-time highs and outperforming gold, driven by industrial demand and a potential supply squeeze. Some are pointing to technical indicators suggesting further upside, while others remain cautious due to short-term volatility.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics ($AVTX) is trending due to discussions around potential long-term gains and recent options activity. Community members are actively sharing potential entry and exit points for call and put options, with some citing chart analysis as a reason for optimism. An analyst recently reaffirmed a price target with significant upside, focusing on the company's hidradenitis suppurativa trials and new leadership.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

SQD is experiencing significant volatility, with community members actively discussing recent price swings and potential for both gains and losses. Chatter revolves around speculation of AI news driving the price, possible pump-and-dump schemes, and the impact of its acquisition by RZLV. Some traders express optimism for a rebound, while others are wary of potential manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health...

Ginkgo Bioworks (NYSE:DNA) Releases Earnings Results, Misses Expectations By $0.21 EPS

Ginkgo Bioworks (NYSE:DNA - Get Free Report) released its earnings results on Thursday. The company reported ($1.45) EPS for the quarter, missing the consensus estimate of ($1.24) by ($0.21). Ginkgo...

Ginkgo Bioworks (NYSE:DNA) Shares Gap Down After Earnings Miss

Ginkgo Bioworks (NYSE:DNA) Shares Gap Down on Disappointing Earnings...

Ginkgo Bioworks Holdings Q3 Loss Widens

(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) on Thursday reported third-quarter net loss of $80.76 million or $1.45 per share, compared to $56.40 million or $1.08 per share in the comparable...

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results Ginkgo Bioworks Reports Third Quarter 2025 Financial Results PR Newswire BOSTON, Nov. 6, 2025 Ginkgo provides an update on its third...

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership...

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation PR Newswire BOSTON, Oct. 30, 2025 Presentation and...

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $12.74, signifying a -4.85% move from its prior day's close.

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program Ginkgo Bioworks in Partnership with STRM.BIO...

Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.78, marking a -2.67% move from the previous day.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DNA News

DNAGinkgo Bioworks Holdings Inc - Ordinary Shares - Class A